Identification of LOX as a candidate prognostic biomarker in Glioblastoma multiforme

BACKGROUND: Glioblastoma multiforme (GBM) is the most malignant type of glioma. GBM tumors grow rapidly, have a high degree of malignancy, and are characterized by a fast disease progression. Unfortunately, there is a lack of effective treatments. An effective strategy for the treatment of GBM would...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Erheng, Li, Wenjuan, Jian, Li-peng, Yin, Shi, Yang, Shuaifeng, Zhao, Heng, Huang, Wei, Zhang, Yongfa, Zhou, Hu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423882/
https://www.ncbi.nlm.nih.gov/pubmed/37544033
http://dx.doi.org/10.1016/j.tranon.2023.101739

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423882/
https://www.ncbi.nlm.nih.gov/pubmed/37544033
http://dx.doi.org/10.1016/j.tranon.2023.101739

Ejemplares similares